Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content

Tuberculosis Epidemiologic Studies Consortium I (TBESC I)

Publications

Peer-reviewed Journal Articles

  • McNabb SJ, Surdo AM, Redmond A, Cobb J, Wiley J, Chakrabarti S, Duncan H, Qualls N, Moore M.  Applying a new conceptual framework to evaluate tuberculosis surveillance and action performance and measure the costs, Hillsborough County, Florida, 2002.  Ann Epidemiol 2004;14:640-5.
  • Sterling TR, Bethel J, Goldberg S, Weinfurter P, Yun L, Horsburgh CR, Tuberculosis Epidemiologic Studies Consortium.  The scope and impact of treatment of latent tuberculosis infection in the United States and Canada.  Am J Respir Crit Care Med 2006;173:927-31.
  • Miller TL, Hilsenrath P, Lykens K, McNabb SJ, Moonan PK, Weis SE.  Using cost and health impacts to prioritize the targeted testing of tuberculosis in the United States.  Ann Epidemiol 2006;16:305-12.
  • Katz D, Albalak R, Wing JS, Combs V; Tuberculosis Epidemiologic Studies Consortium.  Setting the agenda: a new model for collaborative tuberculosis epidemiologic research.  Tuberculosis 2007;87:1-6. 
  • Li J, Marks SM, Driver CR, Diaz FA, Castro AF 3rd, de Regner AF, Gibson AE, Dokubo-Okereke K, Munsiff SS; Tuberculosis Epidemiologic Studies Consortium.  Human immunodeficiency virus counseling, testing, and referral of close contacts to patients with pulmonary tuberculosis: feasibility and costs.  J Public Health Manag Pract. 2007;13:252-62.
  • Hance FL, Steingart KR, Hahn CG, Pascopella L, Nolan CM. Field assessment of a model tuberculosis outbreak response plan for low-incidence areas.  BMC Public Health 2007;7:307.
  • Cook VJ, Sun SJ, Tapia J, Muth SQ, Arguello DF, Lewis BL, Rothenberg RB, McElroy PD. Transmission network analysis in tuberculosis contact investigations.  J Infect Dis 2007;196:1517-27.
  • Lobato MN, Sun SJ, Moonan PK, Weis SE, Saiman L, Reichard AA, Feja K; Zero Tolerance for Pediatric TB Study Group.  Underuse of effective measures to prevent and manage pediatric tuberculosis in the United States.  Arch Pediatr Adolesc Med. 2008;162:426-31. 
  • Davidow AL, Katz D, Reves R, Bethel J, Ngong L; Tuberculosis Epidemiologic Studies Consortium.  The challenge of multisite epidemiologic studies in diverse populations: design and implementation of a 22-site study of tuberculosis in foreign-born people.  Public Health Rep 2009;124:391-9.
  • Talati NJ, Seybold U, Humphrey B, Aina A, Tapia J, Weinfurter P, Albalak R, Blumberg HM. Poor concordance between interferon-gamma release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis. 2009;9:9-15.
  • Horsburgh CR Jr, Goldberg S, Bethel J, Chen S, Colson PW, Hirsch-Moverman Y, Hughes S, Shrestha-Kuwahara R, Sterling TR, Wall K, Weinfurter P; Tuberculosis Epidemiologic Studies Consortium.  Latent TB infection treatment acceptance and completion in the United States and Canada.  Chest 2010;137:401-9.
  • Phillips VL, Teweldemedhin B, Ahmedov S, Cobb J, McNabb SJ.  Evaluation of program performance and expenditures in a report of performance measures (RPM) via a case study of two Florida county tuberculosis programs.  Eval Program Plann 2010;33:373-8.
  • Weinfurter P, Blumberg HM, Goldbaum G, Royce R, Pang J, Tapia J, Bethel J, Mazurek GH, Toney S, Albalak R; Tuberculosis Epidemiological Studies Consortium.  Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups.  Int J Tuberc Lung Dis 2011;15:1056-61. 
  • Lurie S, Weis S, Munguia G. Roles of Hispanic service organizations in tuberculosis education and health promotion. Chapter 12 in: Building Community Capacity: Minority and Immigrant Populations. R. Caron and J. Merrick, editors. N.Y.: Nova Science Publishers, 2012. 
  • Moonan PK, Teeter LD, Salcedo K, Ghosh S, Ahuja SD, Flood J, Graviss EA.  Transmission of multidrug-resistant tuberculosis in the USA: a cross-sectional study.  Lancet Infect Dis 2013;13:777-84.
  • Pettit AC, Bethel J, Hirsch-Moverman Y, Colson PW, Sterling TR; Tuberculosis Epidemiologic Studies Consortium.  Female sex and discontinuation of isoniazid due to adverse effects during the treatment of latent tuberculosis.  J Infect 2013;67:424-32. 
  • Colson PW, Hirsch-Moverman Y, Bethel J, Vempaty P, Salcedo K, Wall K, Miranda W, Collins S, Horsburgh CR; Tuberculosis Epidemiologic Studies Consortium.  Acceptance of treatment for latent tuberculosis infection: prospective cohort study in the United States and Canada. Int J Tuberc Lung Dis 2013;17:473-9. 
  • Painter JA, Graviss EA, Hai HH, Nhung DT, Nga TT, Ha NP, Wall K, Loan le TH, Parker M, Manangan L, O'Brien R, Maloney SA, Hoekstra RM, Reves R.  Tuberculosis screening by tuberculosis skin test or QuantiFERON-TB Gold In-Tube Assay among an immigrant population with a high prevalence of tuberculosis and BCG vaccination.  PLoS One 2013;8:e82727.
  • Marks SM, Cronin W, Venkatappa T, Maltas G, Chon S, Sharnprapai S, Gaeddert M, Tapia J, Dorman SE, Etkind S, Crosby C, Blumberg HM, Bernardo J.  The health-system benefits and cost-effectiveness of using Mycobacterium tuberculosis direct nucleic acid amplification testing to diagnose tuberculosis disease in the United States.  Clin Infect Dis 2013;57:532-42.
  • Hirsch-Moverman Y, Wall K, Weinfurter P, Munk E, Moran JA, Maiuris A, Khan A, DeLuca N; TB Epidemiologic Studies Consortium.  Acceptability of interferon-gamma release assays among healthcare workers who receive routine employee tuberculosis testing.  Int J Occup Environ Health 2013;19:319-24.
  • Walter ND, Painter J, Parker M, Lowenthal P, Flood J, Fu Y, Asis R, Reves R; Tuberculosis Epidemiologic Studies Consortium.  Persistent latent tuberculosis reactivation risk in United States immigrants.  Am J Respir Crit Care Med 2014;189:88-95.
  • Miller TL, Carlson EK, Lackan, NA. Playing to our Strengths: An Academic/Health Department Collaboration to Facilitate Public Protections Against Tuberculosis. Frontiers in Public Health Services and Systems Research 2014; 3:(2),Article 3.
  • Dorman SE, Belknap R, Graviss EA, Reves R, Schluger N, Weinfurter P, Wang Y, Cronin W, Hirsch-Moverman Y, Teeter LD, Parker M, Garrett DO, Daley CL; Tuberculosis Epidemiologic Studies Consortium.  Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.  Am J Respir Crit Care Med 2014;189:77-87.
  • Fiske CT, Yan FX, Hirsch-Moverman Y, Sterling TR, Reichler MR; Tuberculosis Epidemiologic Studies Consortium. Risk factors for treatment default in close contacts with latent tuberculous infection. Int J Tuberc Lung Dis. 2014;18:421-7. 
  • Colson PW, Couzens GL, Royce RA, Kline T, Chavez-Lindell T, Welbel S, Pang J, Davidow A, Hirsch-Moverman Y; Tuberculosis Epidemiologic Studies Consortium (TBESC).  Examining the impact of patient characteristics and symptomatology on knowledge, attitudes, and beliefs among foreign-born tuberculosis cases in the US and Canada.  J Immigr Minor Health 2014;16:125-35.
  • Pang J, Teeter LD, Katz DJ, Davidow AL, Miranda W, Wall K, Ghosh S, Stein-Hart T, Restrepo BI, Reves R, Graviss EA; Tuberculosis Epidemiologic Studies Consortium. Epidemiology of tuberculosis in young children in the United States.  Pediatrics 2014;133:e494-504.
  • Hoger S, Lykens K, Beavers SF, Katz D, Miller TL.  Longevity loss among cured tuberculosis patients and the potential value of prevention.  Int J Tuberc Lung Dis 2014;18:1347-52
  • Pascopella L, Franks J, Marks SM, Salcedo K, Schmitz K, Colson PW, Hirsch-Moverman Y, Flood J, Sayles J.  Opportunities for tuberculosis diagnosis and prevention among persons living with HIV: a cross-sectional study of policies and practices at four large Ryan White Program-Funded HIV clinics.  PLoS One 2014;9:e101313.
  • Marks SM, Flood J, Seaworth B, Hirsch-Moverman Y, Armstrong L, Mase S, Salcedo K, Oh P, Graviss EA, Colson PW, Armitige L, Revuelta M, Sheeran K,  TB Epidemiologic Studies Consortium.  Treatment practices, outcomes, and costs of multidrug-resistant and extensively drug-resistant tuberculosis, United States, 2005-2007. Emerg Infect Dis. 2014 May;20(5):812-21.
  • Aiona K, Lowenthal P, Painter JA, Reves R, Flood J, Parker M, Fu Y, Wall K, Walter ND. Transnational record linkage for tuberculosis surveillance and program evaluation. Public Health Rep 2015;130:475-84.
  • Howley MM, Painter JA, Katz DJ, Graviss EA, Reves R, Beavers SF, Garrett DO; Tuberculosis Epidemiologic Studies Consortium.  Evaluation of QuantiFERON-TB gold in-tube and tuberculin skin tests among immigrant children being screened for latent tuberculosis infection. Pediatr Infect Dis J 2015;34:35-9.
  • Miller TL, Wilson FA, Pang JW, Beavers S, Hoger S, Sharnprapai S, Pagaoa M, Katz DJ, Weis SE.  Mortality hazard and survival after tuberculosis treatment.  Am J Public Health 2015;105:930-7.
  • Hirsch-Moverman Y, Cronin WA, Chen B, Moran JA, Munk E,  Reichler MR; Tuberculosis Epidemiological Studies Consortium.  HIV counseling and testing in tuberculosis contact investigations in the United States and Canada.  Int J Tuberc Lung Dis 2015;19:943–53. 
  • Pagaoa MA, Royce RA, Chen MP, Golub JE, Davidow AL, Hirsch-Moverman Y, Marks SM, Teeter LD, Thickstun PM, Katz DJ; Tuberculosis Epidemiologic Studies Consortium.  Risk factors for transmission of tuberculosis among United States-born African Americans and whites.  Int J Tuberc Lung Dis 2015;19:1485-92.
  • Howley MM, Rouse CD, Katz DJ, Colson PW, Hirsch-Moverman Y, Royce RA; Tuberculosis Epidemiologic Studies Consortium.  Knowledge and attitudes about tuberculosis among U.S.-born blacks and whites with tuberculosis. J Immigr Minor Health 2015;17:1487-95.
  • Hirsch-Moverman Y, Shrestha-Kuwahara R, Bethel J, Blumberg HM, Venkatappa TK, Horsburgh CR, Colson PW; Tuberculosis Epidemiologic Studies Consortium (TBESC).  Latent tuberculous infection in the United States and Canada: who completes treatment and why? Int J Tuberc Lung Dis 2015;19:31-8. 
  • Davidow AL, Katz D, Ghosh S, Blumberg H, Tamhane A, Sevilla A, Reves R; Tuberculosis Epidemiologic Studies Consortium.  Preventing infectious pulmonary tuberculosis among foreign-born residents of the United States.  Am J Public Health 2015;105:e81-8.
  • Marks SM, Hirsch-Moverman Y, Salcedo K, Graviss EA, Oh P, Seaworth B, Flood J, Armstrong L, TB Epidemiologic Studies Consortium.  Characteristics and costs associated with hospitalization for multidrug-resistant tuberculosis care in the United States, 2005-2007.  Int J Tuberc Lung Dis 2016;20:435-41.
  • Agarwal S, Nguyen DT, Lew JD, Teeter LD, Yamal JM, Restrepo BL, Brown EL, Dorman SE, Graviss EA.  Comparing TSPOT assay results between an Elispot reader and manual counts. Tuberculosis 2016;101S:S92-S98.
  • Agarwal S, Nguyen DT, Lew JD, Teeter LD, Yamal JM, Restrepo BL, Brown EL, Dorman SE, Graviss EA.  Differential positive TSPOT assay responses to ESAT-6 and CFP-10 in health care workers.  Tuberculosis 2016;101S:S83-S91. 
  • Teeter LD, Vempaty P, Nguyen DT, Tapia J, Sharnprapai S, Ghosh S, Kammerer JS, Miramontes R, Cronin WA, Graviss EA, Tuberculosis Epidemiologic Studies Consortium.  Validation of genotype cluster investigations for Mycobacterium tuberculosis: application results for 44 clusters from four heterogeneous United States jurisdictions.  BMC Infect Dis 2016;16:594.
  • Collins JM, Reves RR, Belknap RW.  High rates of tuberculosis and opportunities for prevention among international students in the U.S. Ann Am Thorac Soc 2016;13:522-8.
  • Royce RA, Colson PW, Woodsong C, Swinson-Evans T, Walton W, Maiuri A, DeLuca N; Tuberculosis Epidemiologic Studies Consortium (TBESC).  Tuberculosis knowledge, awareness, and stigma among African-Americans in three southeastern counties in the USA: a qualitative study of community perspectives.  J Racial Ethn Health Disparities 2017;4:47-58.

 

Top